                               SEQUENCE LISTING

<110> ETHICON, INC.
 
<120> BROAD-SPECTRUM ANTIMICROBIAL COMPOSITIONS BASED ON COMBINATIONS 
      OF TAUROLIDINE AND PROTAMINE AND MEDICAL DEVICES CONTAINING SUCH 
      COMPOSITIONS

<130> ETH5628WOPCT

<140> PCT/US2012/057258
<141> 2012-09-26

<150> 13/248,290
<151> 2011-09-29

<160> 10    

<170> PatentIn version 3.5

<210> 1
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1
Arg Arg Arg Arg Gly Gly Arg Arg Arg Arg 
1               5                   10  


<210> 2
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 2
Val Ser Arg Arg Arg Arg Arg Arg Gly Gly Arg Arg Arg Arg 
1               5                   10                  


<210> 3
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 3
Pro Arg Arg Arg Arg Arg 
1               5       


<210> 4
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 4
Ala Ser Arg Arg Arg Arg Arg Gly Gly Arg Arg Arg Arg 
1               5                   10              


<210> 5
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 5
Pro Arg Arg Arg Arg Ser Ser Pro Pro Arg 
1               5                   10  


<210> 6
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 6
Arg Arg Arg Arg Arg His Ala Ser Thr Lys Leu Lys Arg Arg Arg Arg 
1               5                   10                  15      


Arg Arg Arg His Gly Lys Lys Ser His Lys 
            20                  25      


<210> 7
<211> 30
<212> PRT
<213> Oncorhynchus mykiss

<400> 7
Pro Arg Arg Arg Arg Ala Ser Arg Arg Val Arg Arg Arg Arg Arg Pro 
1               5                   10                  15      


Arg Val Ser Arg Arg Arg Arg Arg Gly Gly Arg Arg Arg Arg 
            20                  25                  30  


<210> 8
<211> 50
<212> PRT
<213> Rattus norvegicus

<400> 8
Ala Arg Tyr Arg Cys Cys Arg Ser Lys Ser Arg Ser Arg Cys Arg Arg 
1               5                   10                  15      


Arg Arg Arg Arg Cys Arg Arg Arg Arg Arg Arg Cys Cys Arg Arg Arg 
            20                  25                  30          


Arg Arg Arg Cys Cys Arg Arg Arg Arg Ser Tyr Thr Phe Arg Cys Lys 
        35                  40                  45              


Arg Tyr 
    50  


<210> 9
<211> 48
<212> PRT
<213> Equus caballus

<400> 9
Ala Arg Tyr Arg Cys Cys Arg Ser Gln Ser Gln Ser Arg Cys Arg Arg 
1               5                   10                  15      


Arg Arg Arg Arg Arg Cys Arg Arg Arg Arg Arg Arg Ser Val Arg Gln 
            20                  25                  30          


Arg Arg Val Cys Cys Arg Arg Tyr Thr Val Leu Arg Cys Arg Arg Arg 
        35                  40                  45              


<210> 10
<211> 34
<212> PRT
<213> Dicentrarchus labrax

<400> 10
Pro Arg Arg Arg Arg Gln Ala Ser Arg Pro Val Arg Arg Arg Arg Arg 
1               5                   10                  15      


Thr Arg Arg Ser Thr Ala Glu Arg Arg Arg Arg Arg Val Val Arg Arg 
            20                  25                  30          


Arg Arg 
        


